FRT-site orientation determines whether the intervening DNA is excised or inverted. When paired sites run in parallel, Flp recombinase can remove the sequence between them. When the sites face opposite directions, the intervening segment can be inverted instead. Designing site orientation therefore allows researchers to select the type of genetic rearrangement required for a particular experiment.
Flp recombinase supplies the enzymatic activity, while FRT sites provide the defined DNA locations recognized by that enzyme. Their partnership restricts rearrangement to DNA segments positioned between matching sites, rather than producing an unspecified change across the genome. This division between enzyme and recognition sequence gives the method its precise and programmable character in molecular genetics.
Predictable rearrangements make it possible to plan genetic changes around the location and orientation of FRT sites. Researchers can remove a selectable marker, alter the arrangement of a transgene, or create a conditional modification without treating the outcome as random. This control is especially valuable when experiments require reproducible DNA organization or regulated gene manipulation.
The target sequence must be placed between a pair of FRT sites, with their relative orientation selected according to the desired outcome. Parallel placement supports excision, whereas opposite orientation supports inversion. This design principle lets investigators connect the physical arrangement of sites in an engineered DNA construct with the rearrangement they intend to study.
A conceptual workflow begins by designing DNA that contains the sequence of interest and an appropriate pair of FRT sites, then providing Flp recombinase in the relevant cells or organism. The resulting DNA rearrangement is examined in relation to the intended excision or inversion. The same logic can support marker removal, conditional modification, or transgene reorganization.
Researchers apply the system when a study needs controlled changes to engineered DNA in cells or organisms. Supported uses include removing selectable marker genes, creating conditional genetic modifications, and controlling transgene organization. In biochemistry and transgenic model development, these applications help connect defined DNA rearrangements with regulated gene manipulation and the analysis of resulting experimental outcomes.